Global Pharmaceutical Market Research Report, Analysis, Opportunities, Revenue, Segmentation, Leading Players : Ken Research

1

• Leading Nations In Otc And Generic Medicine
  Sector Market Outlook Ken Research

2

• According to the study, Pharmaceuticals Global
  Industry Almanac 2013-2022, big pharmaceutical
  companies have made great progress recently with
  assistance from regulatory institutions. This
  progress is evident by the fact that the revenues
  of the worldwide pharmaceutical market crossed a
  trillion U.S. dollars in 2014 and have been on
  the rise ever since. North America is responsible
  for the largest portion of these revenues
  however, as in many other industries the Chinese
  pharmaceutical sector has shown the highest
  growth rates over recent years.

3

• The pharmaceutical market is an enormous sector
  that is constantly evolving. This sector has
  immense contributions in some of the most
  advanced medical studies known to people. Parts
  of the demand for medication are met by OTC
  drugs. OTC drugs are medicines sold directly to
  consumers without the presence of a valid
  prescription from a healthcare professional. OTC
  drugs cure minor ailments like headaches, sprains
  and joint and muscle problems just to name a few.
  The switch to OTC medication by pharmaceutical
  companies is expanding owing to factors like lack
  of regulations or lack of enforcement of
  regulations in developing nations and the
  increasing demand for self medication.
  Asia-Pacific is expected to dominate the market
  due to keen players that promote self medication.
  After Asia-Pacific, Europe is another lucrative
  region in the global OTC drug market with a huge
  and widespread demand. European nations such as
  France and Germany rank among the top five market
  places in the world. Also, German Bayer and
  French Sanofi rank among the best vendors in the
  global OTC drug market. China is predicted to
  evolve into one of the largest OTC drug markets
  by 2021.

4

• OTC drugs are completely opposite to ethical
  drugs and so are generic medicines. A generic
  drug is a medication created to be the same as an
  already marketed brand-name drug in dosage form,
  safety, strength, quality and intended use. These
  similarities mean that a generic medicine works
  in the same way and provides the same clinical
  benefit as its branded version. The most
  important advantage of generic drugs is that they
  are cheaper compared to their branded version as
  they are not required to pay for advertising,
  marketing and promotion. According to reports,
  the global generic drug markets worth in 2021,
  is expected to be nearly double that of 2015.
  Asia-Pacific is expected to show noticeable
  growth in coming years with India and China being
  leaders in the generic drug market.

5

• New drugs like other new products are protected
  by patents that prohibit others from making and
  marketing copies of the same drug. The patent
  protects the companys investment in the drugs
  development by giving the company the sole right
  to sell the drug while the patent is in effect.
  The market for generic drugs is being accelerated
  by patent expirations. The year 2018 is scheduled
  to see a number of patent expirations. These
  include Rituxan by Roche for tackling blood
  cancers and rheumatoid arthritis. The drug is
  among Roches top selling products and already
  faces some competition from biosimilars in
  Europe. The situation is expected to get worse
  for the drug as companies like Mylan and Amgen
  have biosimilars in the works and Sandoz and Teva
  have already reported their respective
  submissions for biosimilars to the FDA for
  review.

6

• The global drug industry is rapidly growing which
  is evident by progress in OTC drugs and generic
  medicine. North America appears as the absolute
  leader in all healthcare sectors but faces
  potentially strong competition from China. France
  and Germany represent Europes potential in the
  pharmaceutical market especially in the OTC
  sector.

7

• To know more, click on the link below
• https//www.kenresearch.com/healthcare/pharmaceuti
  cals/pharmaceuticals-global-industry-almanac/14975
  1-91.html
• Contact UsKen ResearchAnkur Gupta, Head
  Marketing Communicationssales_at_kenresearch.com
• 91-9015378249

8
(No Transcript)